Back
Brightcove 10K Form
Sell
40
BCOV
Brightcove
Last Price:
1.87
Seasonality Move:
4.45%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
2023-11-01 | 10Q | BCOV/Brightcove Quarterly |
2023-08-02 | 10Q | BCOV/Brightcove Quarterly |
2023-05-03 | 10Q | BCOV/Brightcove Quarterly |
2022-11-02 | 10Q | BCOV/Brightcove Quarterly |
2022-08-02 | 10Q | BCOV/Brightcove Quarterly |
2022-04-27 | 10Q | BCOV/Brightcove Quarterly |
Receive BCOV News And Ratings
See the #1 stock for the next 7 days that we like better than BCOV
BCOV Financial Statistics
Sales & Book Value
Annual Sales: | $201.19M |
---|---|
Cash Flow: | $1.41M |
Price / Cash Flow: | 0 |
Annual Sales: | $2.15 |
Price / Book: | 0.88 |
Profitability
EPS (TTM): | -0.54000 |
---|---|
Net Income (TTM): | $-22.89M |
Gross Margin: | $123.83M |
Return on Equity: | -24.12% |
Return on Assets: | -10.36% |
Brightcove Earnings Forecast
Key Brightcove Financial Ratios
- The Gross Profit Margin over the past 15 years for BCOV is 61.55%.
- The Selling, General & Administrative Expenses for BCOV have been equal to 53.66% of Gross Profit Margin.
- The Research & Development expenses have been 18.49% of Revenue.
- The Interest Expense is -0.11% of Operating Income.
- The Net Earning history of BCOV is -11.38% of Total Revenues.
- Per Share Earnings over the last 15 years have been positive in 7 years.
Brightcove Stock Price Chart
Industry, Sector and Symbol
Stock Exchange: | NASDAQ |
---|---|
Industry: | IT Services |
Sector: | Information Technology |
Current Symbol: | BCOV |
CUSIP: | 10921T |
Website: | brightcove.com |
Debt
Debt-to-Equity Ratio: | 0 |
---|---|
Current Ratio: | 0.67 |
Quick Ratio: | 0.5 |
Price-to-Earnings
Trailing P/E Ratio: | 0 |
---|---|
Forward P/E Ratio: | 0 |
BCOV Technical Analysis vs Fundamental Analysis
Sell
40
Brightcove (BCOV)
is a Sell
Is Brightcove a Buy or a Sell?
-
Brightcove stock is rated a Sell
The current Brightcove [BCOV] share price is $1.90. The Score for BCOV is 40, which is 20% below its historic median score of 50, and infers higher risk than normal.